Identifying and Quantifying Mutagenic Impurities in Pharmaceutical Products

June 16, 2020

Source: PharmTech Sponsored eBooks

Issue 10,Volume Sponsored eBook

Page Number: 34–37

Meeting detection challenges presented by nitrosamine impurities Determination of NDMA and nitrosamine impurities using triple-quadrupole LC/MS Determination of genotoxic impurities in ranitidine APIs and drug products